Publication
Fetopatia pelo uso de inibidores da enzima de conversão da angiotensina
dc.contributor.author | Neves, S | |
dc.contributor.author | Santos, R | |
dc.contributor.author | Gomes, C | |
dc.contributor.author | Correia, AJ | |
dc.date.accessioned | 2012-05-08T14:30:36Z | |
dc.date.available | 2012-05-08T14:30:36Z | |
dc.date.issued | 2010 | |
dc.description.abstract | Angiotensin Converting Enzyme Inhibitors (ACEI) are commonly used antihypertensive drugs, although contraindicated during pregnancy by fetopathy association such as renal dysgenesis, oligohydramnios, hipocalvaria, pulmonary hypoplasia, intrauterine growth restriction, and neonatal anuric renal failure. The authors present a clinical report of a child that developed neonatal anuric renal failure with peritoneal dialysis support by an in uterus exposure to ACEI with very good recovery. This case and literature review states the need to avoid ACEI prescription to Young women and it's suspension as soon as possible during pregnancy. | por |
dc.identifier.citation | Acta Med Port. 2010;23(4):697-700. | por |
dc.identifier.uri | http://hdl.handle.net/10400.4/1371 | |
dc.language.iso | por | por |
dc.peerreviewed | yes | por |
dc.subject | Anúria | por |
dc.subject | Criança | por |
dc.subject | Inibidores da Enzima de Conversão da Angiotensina | por |
dc.subject | Insuficiência Renal | por |
dc.subject | Doenças do Feto | por |
dc.title | Fetopatia pelo uso de inibidores da enzima de conversão da angiotensina | por |
dc.title.alternative | Fetopathy associated with exposure to angiotensin converting enzyme inhibitors | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
rcaap.rights | openAccess | por |
rcaap.type | article | por |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Fetopathy associated with exposure to angiotensin converting enzyme inhibitors.pdf
- Size:
- 356.92 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: